SK3 Group, Inc. (SKTO)
SK3 Group, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3,020. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 32.1%. Its beta of -5.46 implies it has historically moved less than the broad market.
SK3 Group, Inc. offers strategic consulting, product authorization, and promotional assistance to medical cannabis organizations situated in California. The company also grants licenses for the commercialization and distribution of a varied range of products. These include the YAK brand of medical marijuana edibles; Canna-Loz, an ingestion method for significant quantities of phyto-cannabinoids; Yeti, a pre-rolled item crafted for pain management; and Dharmanol, an exclusive technological process that isolates, stabilizes, and safeguards the beneficial cannabinoids from hemp and marijuana in their non-intoxicating form. Previously operating as CTT International Distributors, Inc., the company officially rebranded as SK3 Group, Inc. in May 2007. Founded in 2000, its main corporate base is located in Los Angeles, California. SK3 Group, Inc. is an affiliate of Healthcare of Today, Inc.
SK3 Group, Inc. is most often compared with the following Healthcare names: